DiaGen AI / Contact
For platform access, catalog partnering or co-development enquiries.
Platform access. Enterprise use of BLACKCOMB and CYPRESS for small molecule and peptide programmes.
Catalog partnering. The DGEN1-5 KRAS catalog is pre-clinical, IP retained in full by DiaGen, and open to counterparties.
Co-development. Joint programmes on the model shared with Hadasit and UNC-SGC, where partners carry synthesis and validation.
Biosensor licensing. Modular biosensor plus AI analytics for diagnostics manufacturers.
For platform access, catalog partnering or co-development enquiries.
[email protected]